Violich Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.5M | Sell |
109,254
-1,225
| -1% | -$264K | 2.99% | 9 |
|
|
2026
Q1 | $24M | Sell |
110,479
-915
| -0.8% | -$203K | 2.81% | 9 |
|
|
2025
Q4 | $25.5M | Buy |
111,394
+1,018
| +0.9% | +$232K | 2.84% | 9 |
|
|
2025
Q3 | $25.6M | Buy |
110,376
+6,231
| +6% | +$1.27M | 3.04% | 9 |
|
|
2025
Q2 | $19.3M | Sell |
104,145
-12,770
| -11% | -$2.37M | 2.72% | 9 |
|
|
2025
Q1 | $24.5M | Sell |
116,915
-182
| -0.2% | -$35.4K | 3.3% | 9 |
|
|
2024
Q4 | $20.8M | Sell |
117,097
-164
| -0.1% | -$30.2K | 2.71% | 9 |
|
|
2024
Q3 | $23.2M | Buy |
117,261
+775
| +0.7% | +$145K | 3.01% | 9 |
|
|
2024
Q2 | $20M | Buy |
116,486
+1,040
| +0.9% | +$172K | 2.7% | 9 |
|
|
2024
Q1 | $21M | Buy |
115,446
+4,615
| +4% | +$795K | 3.01% | 8 |
|
|
2023
Q4 | $17.2M | Buy |
110,831
+567
| +0.5% | +$82.7K | 2.79% | 9 |
|
|
2023
Q3 | $16.4M | Sell |
110,264
-5,474
| -5% | -$804K | 2.8% | 9 |
|
|
2023
Q2 | $15.6M | Sell |
115,738
-3,500
| -3% | -$513K | 2.51% | 13 |
|
|
2023
Q1 | $19M | Sell |
119,238
-85
| -0.1% | -$13K | 3.24% | 7 |
|
|
2022
Q4 | $19.3M | Sell |
119,323
-200
| -0.2% | -$30.7K | 3.42% | 8 |
|
|
2022
Q3 | $16M | Sell |
119,523
-136
| -0.1% | -$19.5K | 3.02% | 10 |
|
|
2022
Q2 | $18.3M | Sell |
119,659
-212
| -0.2% | -$32.4K | 3.21% | 10 |
|
|
2022
Q1 | $19.4M | Sell |
119,871
-1,002
| -0.8% | -$146K | 2.87% | 8 |
|
|
2021
Q4 | $16.4M | Buy |
120,873
+1,642
| +1% | +$194K | 2.35% | 11 |
|
|
2021
Q3 | $12.9M | Buy |
119,231
+3,590
| +3% | +$410K | 2.07% | 15 |
|
|
2021
Q2 | $13M | Sell |
115,641
-2,955
| -2% | -$333K | 2.19% | 14 |
|
|
2021
Q1 | $12.8M | Buy |
118,596
+795
| +0.7% | +$85K | 2.31% | 13 |
|
|
2020
Q4 | $12.6M | Buy |
117,801
+560
| +0.5% | +$53.8K | 2.44% | 12 |
|
|
2020
Q3 | $10.3M | Sell |
117,241
-6,876
| -6% | -$647K | 2.16% | 16 |
|
|
2020
Q2 | $12.2M | Buy |
124,117
+755
| +0.6% | +$66.5K | 2.67% | 10 |
|
|
2020
Q1 | $9.4M | Sell |
123,362
-847
| -0.7% | -$72.1K | 2.52% | 11 |
|
|
2019
Q4 | $11M | Sell |
124,209
-4,935
| -4% | -$410K | 2.4% | 13 |
|
|
2019
Q3 | $9.78M | Sell |
129,144
-1,795
| -1% | -$123K | 2.35% | 13 |
|
|
2019
Q2 | $9.52M | Buy |
130,939
+610
| +0.5% | +$47.9K | 2.34% | 13 |
|
|
2019
Q1 | $10.5M | Sell |
130,329
-2,300
| -2% | -$188K | 2.66% | 12 |
|
|
2018
Q4 | $12.2M | Sell |
132,629
-1,909
| -1% | -$168K | 3.47% | 9 |
|
|
2018
Q3 | $12.7M | Buy |
134,538
+31,650
| +31% | +$3M | 2.91% | 10 |
|
|
2018
Q2 | $9.53M | Buy |
102,888
+6,400
| +7% | +$625K | 2.4% | 14 |
|
|
2018
Q1 | $9.13M | Hold |
96,488
| – | – | 2.44% | 14 |
|
|
2017
Q4 | $9.33M | Sell |
96,488
-75
| -0.1% | -$7.07K | 2.38% | 14 |
|
|
2017
Q3 | $8.58M | Buy |
96,563
+3,091
| +3% | +$235K | 2.34% | 14 |
|
|
2017
Q2 | $6.78M | Buy |
93,472
+2,200
| +2% | +$148K | 1.98% | 17 |
|
|
2017
Q1 | $5.95M | Buy |
91,272
+405
| +0.4% | +$25.5K | 1.8% | 17 |
|
|
2016
Q4 | $5.53M | Buy |
90,867
+5,295
| +6% | +$323K | 1.7% | 21 |
|
|
2016
Q3 | $5.4M | Sell |
85,572
-190
| -0.2% | -$12.3K | 1.89% | 20 |
|
|
2016
Q2 | $5.31M | Hold |
85,762
| – | – | 1.68% | 20 |
|
|
2016
Q1 | $4.9M | Buy |
85,762
+14,259
| +20% | +$795K | 1.57% | 21 |
|
|
2015
Q4 | $4.24M | Buy |
71,503
+23,025
| +47% | +$1.33M | 1.4% | 25 |
|
|
2015
Q3 | $2.64M | Buy |
48,478
+1,350
| +3% | +$87.9K | 0.92% | 31 |
|
|
2015
Q2 | $3.17M | Buy |
47,128
+3,500
| +8% | +$228K | 1.03% | 29 |
|
|
2015
Q1 | $2.55M | Buy |
43,628
+12,600
| +41% | +$761K | 0.83% | 32 |
|
|
2014
Q4 | $2.03M | Buy |
31,028
+13,029
| +72% | +$821K | 0.65% | 38 |
|
|
2014
Q3 | $1.04M | Buy |
17,999
+7,050
| +64% | +$391K | 0.34% | 47 |
|
|
2014
Q2 | $618K | Sell |
10,949
-75
| -0.7% | -$3.94K | 0.21% | 67 |
|
|
2014
Q1 | $567K | Sell |
11,024
-100
| -0.9% | -$5.05K | 0.2% | 62 |
|
|
2013
Q4 | $587K | Sell |
11,124
-885
| -7% | -$43.5K | 0.21% | 61 |
|
|
2013
Q3 | $537K | Buy |
12,009
+600
| +5% | +$26.6K | 0.21% | 65 |
|
|
2013
Q2 | $472K | Buy |
+11,409
| New | +$499K | 0.19% | 73 |
|
Other funds holding ABBV
Violich Capital Management's ABBV Position: Q2 2026 in Review
Violich Capital Management reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $264K and leaving 109,254 shares worth $27.5M. The position accounts for 2.99% of the portfolio, ranked #9.
Violich Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Violich Capital Management held 109,254 shares of AbbVie worth $27.5M as of Q2 2026.
- Violich Capital Management sold 1,225 AbbVie shares in Q2 2026, an estimated $264K.
- AbbVie made up 2.99% of Violich Capital Management's portfolio in Q2 2026, its #9 holding.
- Violich Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Violich Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.